钙与出血试验:利用单能CT、双能CT和定量磁敏感成像制定慢性颅内磁敏感病灶的诊断标准
前瞻性影像临床试验纳入95例常规T2*磁共振显示磁敏感病灶阳性的患者,分训练集50例(328个病灶)和验证集45例(281个病灶),建立并验证单能CT、双能CT和定量磁敏感成像鉴别出血与钙化的定量诊断标准。最佳分类器分别为单能CT小于68 HU、双能CT钙水平小于15 mg/mL(物质分解值)、定量磁敏感成像大于38 ppb,各标准间总体相互一致,所提标准优于现有已发表标准。作者认为这些标准内部一致性更高,可能应取代现有标准作为金标准。
要点
- 单能CT鉴别出血与钙化的最佳阈值为小于68 HU。
- 双能CT钙水平小于15 mg/mL(物质分解值)提示出血。
- 定量磁敏感成像大于38 ppb提示出血。
英文原文(摘要)· 点击展开
PURPOSE: Chronic susceptibility lesions in the brain can be either hemorrhagic (potentially dangerous) or calcific (usually not dangerous) but are difficult to discriminate on routine imaging. We proposed to develop quantitative diagnostic criteria for single-energy computed tomography (SECT), dual-energy computed tomography (DECT), and quantitative susceptibility mapping (QSM) to distinguish hemorrhage from calcium.
MATERIALS AND METHODS: Patients with positive susceptibility lesions on routine T2*-weighted magnetic resonance of the brain were recruited into this prospective imaging clinical trial, under institutional review board approval and with informed consent. The SECT, DECT, and QSM images were obtained, the lesions were identified, and the regions of interest were defined, with the mean values recorded. Criteria for quantitative interpretation were developed on the first 50 patients, and then applied to the next 45 patients. Contingency tables, scatter plots, and McNemar test were applied to compare classifiers.
RESULTS: There were 95 evaluable patients, divided into a training set of 50 patients (328 lesions) and a validation set of 45 patients (281 lesions). We found the following classifiers to best differentiate hemorrhagic from calcific lesions: less than 68 Hounsfield units for SECT, calcium level of less than 15 mg/mL (material decomposition value) for DECT, and greater than 38 ppb for QSM. There was general mutual agreement among the proposed criteria. The proposed criteria outperformed the current published criteria.
CONCLUSIONS: We provide the updated criteria for the classification of chronic positive susceptibility brain lesions as hemorrhagic versus calcific for each major clinically available imaging modality. These proposed criteria have greater internal consistency than the current criteria and should likely replace it as gold standard.
引用
- Schellingerhout D, Jacobsen M, Le Roux L, et al. The Calcium Versus Hemorrhage Trial: Developing Diagnostic Criteria for Chronic Intracranial Susceptibility Lesions Using Single-Energy Computed Tomography, Dual-Energy Computed Tomography, and Quantitative Susceptibility Mapping. Invest Radiol. 2021. PMID: 33534507. doi:10.1097/RLI.0000000000000758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。